Faculty profile

Razq Hakem

Back to faculty

ProfessorDepartment of Medical BiophysicsUniversity of Toronto

Razq Hakem

Professor

Department of Medical Biophysics

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
58 publications in the last five years, latest in 2026.
Senior (last) author on 17 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

172

Publications

18,320

Citations

104

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer.
Molecular cancer therapeutics · 2026
Paradoxical oncogenic effects of hepatic Brca1 through modulating Bhmt.
Scientific reports · 2026
Supplementary Table S3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer
2026

All 172 publications

From the 150 most recent of 172 publications.

CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer.

Patel UA, Shi MY, Kazan JM, Nixon KCJ, Ran X, Nair SN, Huang O, Song L, Aparnathi MK, He MY, Bakhtiari M, Krishnan R, Hessenow RK, Philip V, Ketela T, Jendrossek V, Hakem R, He HH, Kridel R, Lok BH

Molecular cancer therapeutics20261 citationsOpen Access

DOI: 10.1158/1535-7163.mct-24-0861 PMID: 40899441

Paradoxical oncogenic effects of hepatic Brca1 through modulating Bhmt.

Ghebreselassie M, Park YJ, Nakib D, Dodington D, Patel P, Won S, Hakem A, Hakem R, MacParland S, Woo M

Scientific reports2026Open Access

DOI: 10.1038/s41598-026-39581-6 PMID: 41781465

Supplementary Table S3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Ujas A. Patel, Mary Y. Shi, Jalal M. Kazan, Kevin C. J. Nixon, Xiaozhuo Ran, Sree Narayanan Nair, Olivia Huang, Lifang Song, Mansi K. Aparnathi, Michael Y. He, Mehran Bakhtiari, Rehna Krishnan, Razan K. Hessenow, Vivek Philip, Troy W. Ketela, Verena Jendrossek, Razqallah Hakem, Housheng H. He, Robert Kridel, Benjamin Hoyin Lok

2026Open Access

DOI: 10.1158/1535-7163.30986270

Supplementary Figure 2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.30986288

Supplementary Table S2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.30986273

Adipocyte caspase-8 but not RIPK3 promotes adiposity.

Chan CK, Aslam R, Yang F, Panesar A, Hakem A, Hakem R, Gaisano HY, Winer DA, Luk CT

Cell death discovery2026Open Access

DOI: 10.1038/s41420-026-03201-z PMID: 42337230

Data from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.c.8227088

Supplementary Table S1 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.30986276

Supplementary Figure 3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.30986285

Supplementary Methods from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

2026Open Access

DOI: 10.1158/1535-7163.30986279

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Razq Hakem

Research

Latest papers

CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer.

Paradoxical oncogenic effects of hepatic Brca1 through modulating Bhmt.

Supplementary Table S3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Supplementary Figure 2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Supplementary Table S2 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Adipocyte caspase-8 but not RIPK3 promotes adiposity.

Data from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Supplementary Table S1 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Supplementary Figure 3 from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Supplementary Methods from CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer

Frequent collaborators

Razqallah Hakem

Otto Sanchez

Tak Mak

Minna Woo

Leonardo Salmena

Benjamin Lok

Brian Raught

Yongdong Wang

Karim Mekhail

Robert Kridel

Aaron Schimmer

Rama Khokha

Pamela Ohashi

Shane Harding

Ming Tsao

Josef Penninger

Thomas Kislinger

Cynthia Luk

Andrea Jurisicova

Ming-Sound Tsao

Mark Minden

Jim Woodgett

Rob Rottapel

Rima Al-awar